Manufacturers see off push from investors to share Covid vaccine formula
Three of the world's biggest Covid vaccine makers have seen off attempts to make them share the know-how to make their jabs.
But his argument that the "global inequity would lead to many more deaths" was not enough to convince shareholders. Only 24% backed the idea of the company undertaking a feasibility study into transferring intellectual property and technical know-how to manufacturers in low and middle-income countries.
"I think a significant amount of the investors have shown us support of these steps," Frank Wagemans, Achmea's senior engagement specialist told the BBC. "The global economic recovery continues to be constrained by unequal access to tools to prevent and treat Covid-19," International Monetary Fund economist Ruchir Agarwal told the BBC.Media caption,Last year Moderna delivered 807 million doses of Covid vaccines, which made it a profit of $12.2bn. It says that more than a quarter of these went to low or middle-income countries.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna to ask FDA to approve COVID vaccine for six-months-old and upModerna plans to submit an application to the FDA for the authorization of its COVID-19 vaccine among kids between the ages of six months to five years. Moderna's trial involved around 6,700 kids.
Read more »
Moderna asks US to authorize Covid-19 vaccine for children under age sixModerna submits data to FDA, in hopes low-dose shots to protect babies, toddlers and preschoolers will be available by summer
Read more »
Head of Covid vaccine taskforce to lead new unit for HRT shortagesHormone replacement therapy taskforce led by Madelaine McTernan aims to ensure access to menopause medicines
Read more »
U.S. Is Getting Closer to Having COVID-19 Vaccines for Children Under Six Years OldModerna has requested authorization for its vaccine to be used in the youngest children
Read more »
Moderna seeks US approval for Covid jab for kids under the age of sixTrials showed the jab was 37 per cent effective for two and five-year-olds and 51 per cent for children between six months and the age of two
Read more »
‘Thrown to the wolves’: Covid care home ruling is bitter victory for relativesAnalysis: The high court found policy that sent untested people into homes was illegal and irrational
Read more »